Abbott Laboratories Beats EPS Estimates, McDonald’s Corporation Misses

0
Abbott Laboratories Beats EPS Estimates, McDonald’s Corporation Misses
By Abbott LaboratoriesUploaded by Gump Stump at en.wikipedia [Public domain], <a href="https://commons.wikimedia.org/wiki/File%3AAbbottLaboratories.svg">via Wikimedia Commons</a>

Abbott Laboratories and McDonald’s released their latest earnings reports before opening bell this morning. Abbott posted adjusted earnings of 47 cents, a 38% increase that beat guidance, on revenue of $4.9 billion, a 10% increase with double-digit growth in emerging markets. Analysts had been expecting earnings of 42 cents per share on $4.85 billion in revenue.

McDonald’s posted earnings of 84 cents per diluted share on $5.96 billion in revenue for the first quarter. Analysts had been expecting earnings of $1.06 per share on $5.96 billion in revenue. In the same quarter a year ago, the fast food chain posted $6.7 billion in revenue.

John Buckingham: Busting the Myths & Seven “Valuable” Themes for 2021 [ValueWalk Webinar slides and video]

John BuckinghamJohn Buckingham's presentation titled, 'Busting the Myths & Seven "Valuable" Themes for 2021'. The webinar  for ValueWalk Premium members took place on 2/23/2021, and was followed by a Q&A. Stay tuned for our next webinar, Q4 2020 hedge fund letters, conferences and more John Buckingham Principal, Portfolio Manager, Kovitz Editor of The Prudent Speculator newsletter Read More


Key metrics from Abbott Laboratories’ earnings report

Abbott Laboratories reported GAAP earnings of 35 cents per share. International sales rose 13.6% operationally and 3.5% on a reported basis. Sales in emerging markets rose 20.6% operationally and 13% on a reported basis.

Sales from the company’s Nutrition segment rose 6.3% to $1.669 billion for the quarter, including $685 million in U.S. sales and $984 million in international sales. Diagnostics revenue increased 6% operationally to $1.093 billion, including $327 million in the U.S. and $766 million internationally.

The drug maker’s Established Pharmaceuticals division recorded a 43% operational increase in sales, which rose to $897 million, all of which was international. Medical Devices revenue increased 1% to $1.226 billion, including $485 million in the U.S. and $741 million internationally.

The drug maker also left its previously provided guidance unchanged. Management expects full year earnings of between $2.10 and $2.20 per share and GAAP earnings of between $1.33 and $1.43 per share.

Key metrics from McDonald’s earnings

McDonald’s reported earnings were 84 cents, compared to $1.21 per share in the same quarter a year ago. The fast food chain said special items of 17 cents per share weighed on the reported results. The company also said it took a 9-cent per share hit for foreign currencies. In constant currencies, McDonald’s earnings per share fell 11 cents or 9%.

Same store sales fell 2.3% in the first quarter, which was slightly worse than the consensus estimate of a 2% decline year over year. U.S. same store sales fell 2.6% in the quarter, again worse than the consensus estimate of a 2% decline from last year.

No posts to display